Literature DB >> 18765135

Fibromyalgia: an update and immunological aspects.

Eduardo S Paiva1, Evelin Diana Goldenberg Mariano da Costa, Morton Scheinberg.   

Abstract

Fibromyalgia syndrome (FMS) is now understood as a chronic pain syndrome, and recent evidence indicates it is not a pure psychosomatic disorder. We review the current knowledge in FMS pain pathways, focusing on the central system sensitization phenomenon and the abnormalities in the inhibitory pain systems. Chronic headache is one of the most common symptoms in FMS, and better knowledge of their common pathophysiologic features can help us understand both conditions better. These features include the nerve growth factor actions and failure of the endocannabinoid system. In addition, we review new immunological aspects of FMS, both in their humoral (autoantibodies, antipolymer antibodies) and cytokine (interleukin-2) aspects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765135     DOI: 10.1007/s11916-008-0054-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  59 in total

1.  The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome.

Authors:  J Alexander Cole; Jason M Yeaw; Jennifer A Cutone; Braden Kuo; Zhiping Huang; David L Earnest; Alexander M Walker
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Fibromyalgia and interleukin-2 therapy for malignancy.

Authors:  D J Wallace; K Margolin; P Waller
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

3.  The natural history of fibromyalgia.

Authors:  D T Felson; D L Goldenberg
Journal:  Arthritis Rheum       Date:  1986-12

4.  Fibromyalgia is common in patients with transformed migraine.

Authors:  M F Peres; W B Young; A O Kaup; E Zukerman; S D Silberstein
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

5.  Lyme disease associated with fibromyalgia.

Authors:  H Dinerman; A C Steere
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

6.  Hyperexcitability in fibromyalgia.

Authors:  J Sörensen; T Graven-Nielsen; K G Henriksson; M Bengtsson; L Arendt-Nielsen
Journal:  J Rheumatol       Date:  1998-01       Impact factor: 4.666

7.  Fibromyalgia--are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs.

Authors:  J Sörensen; A Bengtsson; J Ahlner; K G Henriksson; L Ekselius; M Bengtsson
Journal:  J Rheumatol       Date:  1997-08       Impact factor: 4.666

8.  Antipolymer antibodies in Danish fibromyalgia patients.

Authors:  B Jensen; I Hechmann Wittrup; A Wiik; H Bliddal; A S Friis; J K McLaughlin; B Danneskiold-Samsøe; J H Olsen
Journal:  Clin Exp Rheumatol       Date:  2004 Mar-Apr       Impact factor: 4.473

9.  Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  J Rheumatol       Date:  2004-04       Impact factor: 4.666

10.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Authors:  Richard H Gracely; Frank Petzke; Julie M Wolf; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2002-05
View more
  2 in total

1.  Association between Helicobacter pylori infection and fibromyalgia syndrome.

Authors:  Christos Zavos; Jannis Kountouras; Panagiotis Katsinelos; Stergios A Polyzos; Georgia Deretzi; Nikolaos Zavos; Emmanouel Gavalas; Ioannis Pilpilidis; Dimitrios Tzilves
Journal:  Clin Rheumatol       Date:  2010-12-29       Impact factor: 2.980

2.  Relevance of Religiosity for Coping Strategies and Disability in Patients with Fibromyalgia Syndrome.

Authors:  Alexandra Braun; Dimitar Evdokimov; Johanna Frank; Paul Pauli; Thomas Wabel; Nurcan Üçeyler; Claudia Sommer
Journal:  J Relig Health       Date:  2021-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.